Sonnet BioTherapeutics Holdings, Inc. (SONN)

NASDAQ: SONN · Real-Time Price · USD

4.850

+0.300 (6.59%)

At close: Nov 24, 2025, 4:00 PM EST

4.800

-0.050 (-1.03%)

Pre-market: Nov 25, 2025, 7:18 AM EST

Revenue by Product

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2014 - 2018
Period Ending	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Dec '19 Dec 31, 2019	2014 - 2018
Immuno-oncology Treatments	18.63K	Log In	Log In	Log In	Log In	Upgrade
Immuno-oncology Treatments Growth	-87.40%	Log In	Log In	Log In	Log In	Upgrade
Restaurant	-	Log In	Log In	Log In	Log In	Upgrade
Franchise	-	Log In	Log In	Log In	Log In	Upgrade
Gaming	-	Log In	Log In	Log In	Log In	Upgrade
Management Fee Income	-	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2014 - 2018
Period Ending	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Dec '19 Dec 31, 2019	2014 - 2018
United States	18.63K	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-87.40%	Log In	Log In	Log In	Log In	Upgrade
United States and United Kingdom	-	Log In	Log In	Log In	Log In	Upgrade